Cardiovascular Diseases Research in Nevada
Cardiovascular Diseases Research (93.837) awarded $5.3 million to recipients in Nevada in 10 grants from fiscal 2021 to 2025, less than 0.1% of the program's national total. Board of Regents of Nevada System of Higher Education received the most, $4.5 million.
- Awarded in Nevada$5.3 million
- Awards10
- Share of the programless than 0.1%
- Rank among states45th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 4 | -$160,027 |
| FY 2022 | 4 | $1.3 million |
| FY 2023 | 1 | $461,122 |
| FY 2024 | 3 | $1.5 million |
| FY 2025 | 5 | $2.2 million |
Recipients in Nevada
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Board of Regents of Nevada System of Higher Education | Colleges and universities | 8 | $4.5 million |
| Board of Regents of Nevada System of Higher Education | Colleges and universities | 1 | $492,194 |
| Fibroplate Inc | Small businesses | 1 | $253,688 |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Nevada?
$5.3 million from fiscal 2021 to 2025, across 10 awards. Nevada ranks 45th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Nevada?
The largest recipient is Board of Regents of Nevada System of Higher Education, with $4.5 million in 8 awards. Next are Board of Regents of Nevada System of Higher Education and Fibroplate Inc.
Can organizations in Nevada apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Nevada
- Grants to States for Medicaid
- Highway Planning and Construction
- Federal-State Partnership for Intercity Passenger Rail
- Education Stabilization Fund
- National School Lunch Program
- Title I Grants to Local Educational Agencies
- Child Care and Development Block Grant
- Airport Improvement Program, Infrastructure Investment and Jobs Act Programs, and COVID-19 Airports Programs
- Federal Transit Formula Grants
- Special Education Grants to States